Combined Laser-surgical Technology of RRD Treatment

  • STATUS
    Recruiting
  • participants needed
    50
  • sponsor
    The S.N. Fyodorov Eye Microsurgery State Institution
Send
Updated on 5 August 2020
See if I qualify

Summary

Purpose: to assess the efficacy and safety of combined laser-surgical technology of RRD treatment

Description

The study takes place in the S.N. Fyodorov "Eye Microsurgery" Federal State Institution located in Moscow, Russian Federation.

The study will include 50 patients with rhegmatogenous retinal detachment due to a horseshoe-tear. In addition to the standard ophthalmological examination, all patients will undergo wide-field optical coherence tomography to determine the extension and localization of the vitreoretinal traction zone. The obtained data will be used to planning the 1st step of laser-surgical treatment. All patients will undergo a combined laser-surgical technology, which includes 3 steps: 1) Nd-YAG laser excision of the vitreoretinal traction zone 2) pneumatic retinopexy (10% C3F8) 3) barrier laser photocoagulation around retinal break after retinal attachment.

The patients are going to be followed up for at least 1 year, the main outcome measures are postoperative primary and final anatomic outcome, BCVA and complications.

Details
Condition Rhegmatogenous Retinal Detachment
Age 18years - 60years
Treatment Combined laser-surgical technology of RRD treatment
Clinical Study IdentifierNCT04403750
SponsorThe S.N. Fyodorov Eye Microsurgery State Institution
Last Modified on5 August 2020

Eligibility

 Yes No Not Sure

Inclusion Criteria

Rhegmatogenous retinal detachment extending from the 9-o'clock to the 3-o'clock meridians
Superior retinal break from 9 o'clock to 3 o'clock
Single retinal break not greater than 1 clock hours in size
Physically and mentally co-operated in post-operative head positioning
No (or minimal) proliferative vitreoretinopathy
None or mild vitreous hemorrhage

Exclusion Criteria

Severe concomitant eye pathologies (glaucoma, diabetic retinopathy, macular hole, traumas); OR
Ocular media opacities
Previous ocular surgeries
Age <18 years
Previous retinal detachment (index eye)
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.